News
Rituximab bests mycophenolate in pemphigus vulgaris
MADRID – “Rituximab has a superior overall benefit/risk profile, compared to mycophenolate mofetil, in patients with moderate to severe pemphigus...
News
Psoriasis registry data provide evidence that adalimumab reduces mortality
MADRID – The 10-year results from the real-world ESPRIT registry paint a highly favorable picture.
News
New themes emerging about antipsychotic maintenance therapy
COPENHAGEN – “Polypharmacy might not be so bad.” – Dr. Mark Weiser
News
TAVR, SAVR share same infective endocarditis risk
PARIS – “Be aware, be careful, and provide appropriate antibiotic prophylaxis, just as surgeons do in SAVR,” said Dr. Laurent Fauchier.
Video
Novel cardiac troponin protocol rapidly rules out MI
PARIS – Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission...
News
Moderate aortic stenosis just as deadly as severe AS
PARIS – The current echocardiographic definition of moderate aortic stenosis may greatly underestimate risk.
News
Cannabis-using MS patients improve cognition with 28 days of abstinence
STOCKHOLM – “It’s good for neurologists to know that, if they prescribe cannabis or their patient is self-medicating and chooses to stop, their...
News
Early maternal anxiety tied to adolescent hyperactivity
COPENHAGEN – Maternal somatic anxiety during pregnancy and toddlerhood increases a child’s risk of hyperactivity symptoms in adolescence.
News
Lumateperone for schizophrenia shows safety, tolerability in long-term study
COPENHAGEN – One-quarter of patients showed clinically meaningful weight reduction.
News
Skip supplemental O2 in nonhypoxic ACS
PARIS –
News
Virtual dark therapy tames manic episodes
COPENHAGEN – Three days of wearing blue light–blocking glasses brought major clinical improvements in an RCT.
News
Deep transcranial magnetic stimulation alleviates OCD symptoms
COPENHAGEN – This noninvasive therapy can stimulate brain targets 3-5 cm below the skull, unlike standard TMS.
News
Esketamine nasal spray may get expanded indication
COPENHAGEN – Primary endpoint met in two phase 3 pivotal trials in patients with major depressive disorder symptoms at imminent risk for suicide...
News
ISAR-REACT 5: Prasugrel superior to ticagrelor in ACS
PARIS – This large randomized trial was called practice changing.